← Eichor
Study identifier: NCT07275879 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

Condition: Ureteral Double-J Stent · Urolithiasis · Quality of Life  ·  Sponsor: St. Luke's Clinical Hospital, Russia

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.

This description comes directly from the study's public registry record.

Talk to the study team

Dmitriy Sytnik  ·  +7 931 367 78 58  ·  doc.dmitriysytnik@gmail.com

Yury Mikheev  ·  +79315412190  ·  mikheevyra@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

St. Luke's Clinical HospitalSaint Petersburg, Outside U.S./Canada, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07275879